Ekso Bionics (EKSO) stock slips premarket after ChronoScale AI deal-fueled surge
Ekso Bionics shares fell 8.3% to $9.70 premarket after surging 93.8% Tuesday, following Applied Digital’s plan to merge its cloud unit with Ekso to form ChronoScale. The companies signed a non-binding term sheet, with Applied Digital set to own about 97% of the combined firm. Investors await binding terms, financing details, and SEC filings ahead of a shareholder vote.